The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ASCO's Sunday plenary session will open with results of a 2,109-person global prostate cancer study that showed adding ...

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...

Johnson & Johnson's Erleada, combined with hormone therapy, significantly reduces cancer spread and death risk in high-risk prostate cancer patients, late-stage trial reveals.

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...